PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $201,000 | -27.7% | 52,895 | -3.0% | 0.00% | 0.0% |
| Q4 2019 | $278,000 | -9.2% | 54,540 | -9.9% | 0.00% | 0.0% |
| Q3 2019 | $306,000 | -9.7% | 60,500 | +10.0% | 0.00% | -50.0% |
| Q2 2019 | $339,000 | +38.9% | 55,013 | +4.8% | 0.00% | +100.0% |
| Q1 2019 | $244,000 | +9.4% | 52,486 | -1.1% | 0.00% | 0.0% |
| Q4 2018 | $223,000 | -33.2% | 53,091 | -0.3% | 0.00% | -50.0% |
| Q3 2018 | $334,000 | -14.6% | 53,269 | +9.6% | 0.00% | 0.0% |
| Q2 2018 | $391,000 | +4.3% | 48,584 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $375,000 | +13.3% | 50,282 | -9.5% | 0.00% | +100.0% |
| Q4 2017 | $331,000 | -26.9% | 55,562 | -9.8% | 0.00% | -50.0% |
| Q3 2017 | $453,000 | +1.8% | 61,611 | -5.9% | 0.00% | 0.0% |
| Q2 2017 | $445,000 | -28.0% | 65,505 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $618,000 | – | 65,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|